市場調査レポート

アジア太平洋地域の整形外科用バイオマテリアル市場:2011年:骨移植およびヒアルロン酸粘弾性補助

Asia Pacific Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation

発行 iData Research Inc. 商品コード 203689
出版日 ページ情報 英文 358 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。

ご注意: Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
アジア太平洋地域の整形外科用バイオマテリアル市場:2011年:骨移植およびヒアルロン酸粘弾性補助 Asia Pacific Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation
出版日: 2011年07月01日 ページ情報: 英文 358 Pages
概要

2017年までに、アジア太平洋地域の整形外科用バイオマテリアル(生体材料)市場は16億米ドルに近づくと予測されています。ヒアルロン酸粘弾性補助セグメントが同市場の大半を占めるとみられています。市場は成熟化していますが、アジア太平洋地域の高齢化により今後も成長は続くと見込まれています。

当レポートでは、オーストラリア、日本、韓国、中国に焦点を当て、整形外科用バイオマテリアル市場の装置別収益、2017年までの市場予測、平均販売価格、詳細な競合分析、製造業者の市場シェアと製品ポートフォリオなどをまとめ、概略以下の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 調査手法

  • 調査範囲
  • 調査手法

第3章 アジア太平洋地域の整形外科用バイオマテリアル市場概要

  • イントロダクション
  • 概要
  • 為替レート
  • 市場概要
  • セグメント別市場
  • セグメント別動向分析
  • 国別市場
  • 市場促進因子と阻害因子
  • 競合分析
  • 合併・買収

第4章 国別プロファイル

  • イントロダクション
  • 日本
  • 中国
  • 韓国
  • オーストラリア

第5章 処置件数

  • 概要
    • 適応別
    • セグメント別
    • 国別

第6章 代用骨市場

  • イントロダクション
  • 日本
    • 市場分析と予測
    • 市場促進因子と阻害因子
    • 競合分析
  • 中国
    • 市場分析と予測
    • 市場促進因子と阻害因子
    • 競合分析
  • 韓国
    • 市場分析と予測
    • 市場促進因子と阻害因子
    • 競合分析
  • オーストラリア
    • 市場分析と予測
    • 市場促進因子と阻害因子
    • 競合分析

第7章 骨形成タンパク質増殖因子療法市場

  • イントロダクション
  • オーストラリア
    • 市場分析
    • 市場促進因子と阻害因子
    • 競合分析

第8章 ヒアルロン酸粘弾性補助市場

  • イントロダクション
    • 単回注入製品
    • 3回注入サイクル製品
    • 5回注入サイクル製品
  • 日本
  • 中国
  • 韓国
  • オーストラリア

略語解説

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: iDATA_APOB11_RPT

The Asia-Pacific orthopedic biomaterials market is expected to approach $1.6 billion by 2017. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Asia-Pacific orthopedic biomaterials market.

The Asia-Pacific orthopedic biomaterials report covers the following countries:

  • Japan
  • South Korea
  • Australia
  • China

The segments covered in this report include:

  • autologous bone grafts,
  • bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and synthetics),
  • hyaluronic acid (HA) viscosupplementation,
  • bone morphogenetic protein (BMP) growth factor therapy
  • autologous chondrocyte implantation (ACI)

The market is approaching maturity, but is expected to continue to grow as a result of the aging Asia-Pacific population. BMP growth factor therapy was the fastest growing segment in 2010, increasing almost 7% over the previous year.

This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. TOTAL ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET
  • 1.2. HERFINDAHL INDEX COUNTRY PROFILES
  • 1.3. GROWTH TRENDS BY MARKET SEGMENT
  • 1.4. BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
  • 1.5. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.6. BONE MORPHOGENETIC PROTEIN MARKET
  • 1.7. COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA' S 9-STEP METHODOLOGY
    • 2.2.1 Step 1: Project Initiation & Team Selection
    • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
    • 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
    • 2.2.4 Step 4: Performing Primary Research
    • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
    • 2.2.6 Step 6: Market Forecast and Analysis
    • 2.2.7 Step 7: Identify Strategic Opportunities
    • 2.2.8 Step 8: Final Review and Market Release
    • 2.2.9 Step 9: Customer Feedback and Market Monitoring

ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET

  • 3.1. INTRODUCTION
    • 3.1.1. Growth Factors
    • 3.1.2. Bone Graft Substitutes
    • 3.1.3. Hyaluronic Acid Viscosupplementation
  • 3.2. CURRENCY EXCHANGE RATES
  • 3.3. MARKET OVERVIEW
  • 3.4. MARKET BY SEGMENT
  • 3.5. TREND ANALYSIS BY SEGMENT
  • 3.6. MARKET BY COUNTRY
    • 3.6.1. Total Market
    • 3.6.2. Japan
    • 3.6.3. China
    • 3.6.4. South Korea
    • 3.6.5. Australia
  • 3.7. MARKET DRIVERS AND LIMITERS
    • 3.7.1. Market Drivers
    • 3.7.2. Market Limiters
  • 3.8. COMPETITIVE ANALYSIS
    • 3.8.1. Herfindahl Index
  • 3.9. MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 4.1. INTRODUCTION
    • 4.1.1. Population
    • 4.1.2. GDP per Capita
    • 4.1.3. Price Index
  • 4.2. JAPAN
  • 4.3. CHINA
  • 4.4. SOUTH KOREA
  • 4.5. AUSTRALIA

PROCEDURE NUMBERS

  • 5.1. OVERVIEW
    • 5.1.1. Total Orthopedic Bone Graft Substitute Procedures by Indication
    • 5.1.2. Total Orthopedic Bone Graft Substitute Procedures by Segment
    • 5.1.3. Total Orthopedic Bone Graft Substitute Procedures by Country

BONE GRAFT SUBSTITUTE MARKET

  • 6.1. INTRODUCTION
    • 6.1.1. Volumes Represented per Procedure
  • 6.2. JAPAN
    • 6.2.1. Market Analysis and Forecast
      • 6.2.1.1. Volumes Represented per Procedure
      • 6.2.1.2. Total Synthetic Market
      • 6.2.1.3. Synthetic Spine Market
      • 6.2.1.4. Synthetic Cervical Spine Market
      • 6.2.1.5. Synthetic Thoracolumbar Spine Market
      • 6.2.1.6. Synthetic Trauma and Reconstruction Market
      • 6.2.1.7. Synthetic Craniomaxillofacial Market
    • 6.2.2. Market Drivers and Limiters
      • 6.2.2.1. Market Drivers
      • 6.2.2.2. Market Limiters
    • 6.2.3. Competitive Analysis
  • 6.3. CHINA
    • 6.3.1. Overview
    • 6.3.2. Market Analysis and Forecast
      • 6.3.2.1. Total Allograft Market
      • 6.3.2.2. Allograft Spine Market
      • 6.3.2.3. Allograft Cervical Spine Market
      • 6.3.2.4. Allograft Thoracolumbar Spine Market
      • 6.3.2.5. Allograft Trauma & Reconstruction Market
      • 6.3.2.6. Allograft Craniomaxillofacial Market
      • 6.3.2.7. Total Synthetic Market
      • 6.3.2.8. Synthetic Spine Market
      • 6.3.2.9. Synthetic Cervical Spine Market
      • 6.3.2.10. Synthetic Thoracolumbar Spine Market
      • 6.3.2.11. Synthetic Trauma & Reconstruction Market
      • 6.3.2.12. Synthetic Craniomaxillofacial Market
      • 6.3.2.13. Total DBM Market
      • 6.3.2.14. DBM Spine Market
      • 6.3.2.15. DBM Cervical Spine Market
      • 6.3.2.16. DBM Thoracolumbar Spine Market
      • 6.3.2.17. DBM Trauma & Reconstruction Market
      • 6.3.2.18. DBM Craniomaxillofacial Market
    • 6.3.3. Market Drivers and Limiters
      • 6.3.3.1. Market Drivers
      • 6.3.3.2. Market Limiters
    • 6.3.4. Competitive Analysis
  • 6.4. SOUTH KOREA
    • 6.4.1. Overview
    • 6.4.2. Market Analysis and Forecast
      • 6.4.2.1. Total Allograft Market
      • 6.4.2.2. Allograft Spine Market
      • 6.4.2.3. Allograft Cervical Spine Market
      • 6.4.2.4. Allograft Thoracolumbar Spine Market
      • 6.4.2.5. Allograft Trauma & Reconstruction Market
      • 6.4.2.6. Allograft Craniomaxillofacial Market
      • 6.4.2.7. Total Synthetic Market
      • 6.4.2.8. Synthetic Spine Market
      • 6.4.2.9. Synthetic Cervical Spine Market
      • 6.4.2.10. Synthetic Thoracolumbar Spine Market
      • 6.4.2.11. Synthetic Trauma & Reconstruction Market
      • 6.4.2.12. Synthetic Craniomaxillofacial Market
      • 6.4.2.13. Total Demineralized Bone Matrix Market
      • 6.4.2.14. DBM Spine Market
      • 6.4.2.15. DBM Cervical Spine Market
      • 6.4.2.16. DBM Thoracolumbar Spine Market
      • 6.4.2.17. DBM Trauma & Reconstruction Market
      • 6.4.2.18. DBM Craniomaxillofacial Market
    • 6.4.3. Market Drivers and Limiters
      • 6.4.3.1. Market Drivers
      • 6.4.3.2. Market Limiters
    • 6.4.4. Competitive Analysis
  • 6.5. AUSTRALIA
    • 6.5.1. Overview
    • 6.5.2. Market Analysis and Forecast
      • 6.5.2.1. Total Allograft Market
      • 6.5.2.2. Allograft Spine Market
      • 6.5.2.3. Allograft Cervical Spine Market
      • 6.5.2.4. Allograft Thoracolumbar Spine Market
      • 6.5.2.5. Allograft Trauma & Reconstruction Market
      • 6.5.2.6. Allograft Craniomaxillofacial Market
      • 6.5.2.7. Total Synthetic Market
      • 6.5.2.8. Synthetic Spine Market
      • 6.5.2.9. Synthetic Cervical Spine Market
      • 6.5.2.10. Synthetic Thoracolumbar Spine Market
      • 6.5.2.11. Synthetic Trauma & Reconstruction Market
      • 6.5.2.12. Synthetic Craniomaxillofacial Market
    • 6.5.3. Market Drivers and Limiters
      • 6.5.3.1. Market Drivers
      • 6.5.3.2. Market Limiters
    • 6.5.4. Competitive Analysis

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • 7.1. INTRODUCTION
    • 7.1.1. Overview
    • 7.1.2. Potential Complications
  • 7.2. AUSTRALIA
    • 7.2.1. Market Analysis and Forecast
      • 7.2.1.1. Total BMP Market
    • 7.2.2. Market Drivers and Limiters
      • 7.2.2.1. Market Drivers
      • 7.2.2.2. Market Limiters
    • 7.2.3. Competitive Analysis

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 8.1. INTRODUCTION
    • 8.1.1.1. Single-Injection Products
    • 8.1.1.2. Three-Injection Cycle Products
    • 8.1.1.3. Five-Injection Cycle Products
  • 8.2. JAPAN
    • 8.2.1. Market Analysis and Forecast
      • 8.2.1.1. Total Hyaluronic Acid Viscosupplementation Market
    • 8.2.2. Market Drivers and Limiters
      • 8.2.2.1. Market Drivers
      • 8.2.2.2. Market Limiters
    • 8.2.3. Competitive Analysis
  • 8.3. CHINA
    • 8.3.1. Market Analysis and Forecast
      • 8.3.1.1. Total Hyaluronic Acid Viscosupplementation Market
    • 8.3.2. Market Analysis and Forecast
      • 8.3.2.1. Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market
      • 8.3.2.2. Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market
    • 8.3.3. Market Drivers and Limiters
      • 8.3.3.1. Market Drivers
      • 8.3.3.2. Market Limiters
    • 8.3.4. Competitive Analysis
  • 8.4. SOUTH KOREA
    • 8.4.1. Overview
    • 8.4.2. Market Analysis and Forecast
      • 8.4.2.1. Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market
      • 8.4.2.2. Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market
    • 8.4.3. Market Drivers and Limiters
      • 8.4.3.1. Market Drivers
      • 8.4.3.2. Market Limiters
    • 8.4.4. Competitive Analysis
  • 8.5. AUSTRALIA
    • 8.5.1. Market Analysis and Forecast
    • 8.5.2. Market Drivers and Limiters
      • 8.5.2.1. Market Drivers
      • 8.5.2.2. Market Limiters
    • 8.5.3. Competitive Analysis

ABBREVIATIONS

APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

APPENDIX 3: EMERGING MARKETS

  • 12.1. BONE MORPHOGENETIC PROTEIN MARKET
  • 12.2. AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

LIST OF FIGURES

EXECUTIVE SUMMARY

  • Figure 1-1: Total Orthopedic Biomaterials Market, Asia-Pacific, 2010 (US$M)
  • Figure 1-2: Herfindahl Index by Country, Asia-Pacific, 2010
  • Figure 1-3: Growth Trends, Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Figure 1-4: Procedure Numbers, Bone Graft Substitute Market, Asia-Pacific, 2007 - 2017
  • Figure 1-5: Growth Rates, Hyaluronic Acid Viscosupplementation Market, Asia-Pacific, 2007 - 2017
  • Figure 1-6: Bone Morphogenetic Protein Market, Australia, 2007 - 2017 (US$M)
  • Figure 1-7: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010

RESEARCH METHODOLOGY

ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET

  • Figure 3-1: Exchange Rate for Currencies, 2010
  • Figure 3-2: Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Figure 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2007 - 2017 (US$M)
  • Figure 3-4: Growth Rates by Segment, Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Figure 3-5: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2007 - 2017 (US$M)
  • Figure 3-6: Orthopedic Biomaterials Market by Segment, Japan, 2007 - 2017 (US$M)
  • Figure 3-7: Orthopedic Biomaterials Market by Segment, Japan, 2007 - 2017 (JP¥M)
  • Figure 3-8: Orthopedic Biomaterials Market by Segment, China, 2007 - 2017 (US$M)
  • Figure 3-9: Orthopedic Biomaterials Market by Segment, China, 2007 - 2017 (CNY M)
  • Figure 3-10: Orthopedic Biomaterials Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Figure 3-11: Orthopedic Biomaterials Market by Segment, South Korea, 2007 - 2017 (KR₩ M)
  • Figure 3-12: Orthopedic Biomaterials Market by Segment, Australia, 2007 - 2017 (US$M)
  • Figure 3-13: Orthopedic Biomaterials Market by Segment, Australia, 2007 - 2017 (AU$M)
  • Figure 3-14: Drivers and Limiters, Orthopedic Biomaterials Market, Asia-Pacific, 2010
  • Figure 3-15: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010 (1 of 2)
  • Figure 3-16: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010 (2 of 2)
  • Figure 3-17: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010

COUNTRY PROFILES

  • Figure 4-1: Country Indicators, Asia-Pacific, 2010

PROCEDURE NUMBERS

  • Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2007 - 2017
  • Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2007 - 2017
  • Figure 5-3: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2007 - 2017

BONE GRAFT SUBSTITUTE MARKET

  • Figure 6-1: Total Synthetic Market, Japan, 2007 - 2017 (US$)
  • Figure 6-2: Total Synthetic Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-3: Synthetic Total Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 6-4: Synthetic Total Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-5: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 6-6: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 6-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (US$)
  • Figure 6-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-11: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (US$)
  • Figure 6-12: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (JP¥)
  • Figure 6-13: Drivers and Limiters, Bone Graft Substitute Market, Japan, 2010
  • Figure 6-14: Leading Competitors, Bone Graft Substitute Market, Japan, 2010
  • Figure 6-15: Bone Graft Substitute Market by Segment, China, 2007 - 2017 (US$M)
  • Figure 6-16: Bone Graft Substitute Market by Segment, China, 2007 - 2017 (CNY M)
  • Figure 6-17: Total Allograft Market, China, 2007 - 2017 (US$)
  • Figure 6-18: Total Allograft Market, China, 2007 - 2017 (CNY)
  • Figure 6-19: Allograft Total Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-20: Allograft Total Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-21: Allograft Cervical Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-22: Allograft Cervical Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-23: Allograft Thoracolumbar Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-24: Allograft Thoracolumbar Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-25: Allograft Trauma & Reconstruction Market, China, 2007 - 2017 (US$)
  • Figure 6-26: Allograft Trauma & Reconstruction Market, China, 2007 - 2017 (CNY)
  • Figure 6-27: Allograft Craniomaxillofacial Market, China, 2007 - 2017 (US$)
  • Figure 6-28: Allograft Craniomaxillofacial Market, China, 2007 - 2017 (CNY)
  • Figure 6-29: Total Synthetic Market, China, 2007 - 2017 (US$)
  • Figure 6-30: Total Synthetic Market, China, 2007 - 2017 (CNY)
  • Figure 6-31: Synthetic Total Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-32: Synthetic Total Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-33: Synthetic Cervical Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-34: Synthetic Cervical Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-35: Synthetic Thoracolumbar Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-36: Synthetic Thoracolumbar Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-37: Synthetic Trauma & Reconstruction Market, China, 2007 - 2017 (US$)
  • Figure 6-38: Synthetic Trauma & Reconstruction Market, China, 2007 - 2017 (CNY)
  • Figure 6-39: Synthetic Craniomaxillofacial Market, China, 2007 - 2017 (US$)
  • Figure 6-40: Synthetic Craniomaxillofacial Market, China, 2007 - 2017 (CNY)
  • Figure 6-41: Total DBM Market, China, 2007 - 2017 (US$)
  • Figure 6-42: Total DBM Market, China, 2007 - 2017 (CNY)
  • Figure 6-43: DBM Total Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-44: DBM Total Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-45: DBM Cervical Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-46: DBM Cervical Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-47: DBM Thoracolumbar Spine Market, China, 2007 - 2017 (US$)
  • Figure 6-48: DBM Thoracolumbar Spine Market, China, 2007 - 2017 (CNY)
  • Figure 6-49: DBM Trauma & Reconstruction Market, China, 2007 - 2017 (US$)
  • Figure 6-50: DBM Trauma & Reconstruction Market, China, 2007 - 2017 (CNY)
  • Figure 6-51: DBM Craniomaxillofacial Market, China, 2007 - 2017 (US$)
  • Figure 6-52: DBM Craniomaxillofacial Market, China, 2007 - 2017 (CNY)
  • Figure 6-53: Drivers and Limiters, Bone Graft Substitute Market, China, 2010
  • Figure 6-54: Leading Competitors, Bone Graft Substitute Market, China, 2010
  • Figure 6-55: Bone Graft Substitute Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Figure 6-56: Bone Graft Substitute Market by Segment, South Korea, 2007 - 2017 (KR₩ M)
  • Figure 6-57: Total Allograft Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-58: Total Allograft Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-59: Allograft Total Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-60: Allograft Total Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-61: Allograft Cervical Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-62: Allograft Cervical Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-63: Allograft Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-64: Allograft Thoracolumbar Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-65: Allograft Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-66: Allograft Trauma & Reconstruction Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-67: Allograft Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-68: Allograft Craniomaxillofacial Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-69: Total Synthetic Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-70: Total Synthetic Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-71: Synthetic Total Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-72: Synthetic Total Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-73: Synthetic Cervical Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-74: Synthetic Cervical Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-75: Synthetic Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-76: Synthetic Thoracolumbar Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-77: Synthetic Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-78: Synthetic Trauma & Reconstruction Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-79: Synthetic Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-80: Synthetic Craniomaxillofacial Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-81: Total DBM Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-82: Total DBM Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-83: DBM Total Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-84: DBM Total Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-85: DBM Cervical Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-86: DBM Cervical Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-87: DBM Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-88: DBM Thoracolumbar Spine Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-89: DBM Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-90: DBM Trauma & Reconstruction Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-91: DBM Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$)
  • Figure 6-92: DBM Craniomaxillofacial Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 6-93: Drivers and Limiters, Bone Graft Substitute Market, South Korea, 2010
  • Figure 6-94: Leading Competitors, Bone Graft Substitute Market, South Korea, 2010
  • Figure 6-95: Bone Graft Substitute Market by Segment, Australia, 2007 - 2017 (US$M)
  • Figure 6-96: Bone Graft Substitute Market by Segment, Australia, 2007 - 2017 (AU$M)
  • Figure 6-97: Total Allograft Market, Australia, 2007 - 2017 (US$)
  • Figure 6-98: Total Allograft Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-99: Allograft Total Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-100: Allograft Total Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-101: Allograft Cervical Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-102: Allograft Cervical Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-103: Allograft Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-104: Allograft Thoracolumbar Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-105: Allograft Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$)
  • Figure 6-106: Allograft Trauma & Reconstruction Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-107: Allograft Craniomaxillofacial Market, Australia, 2007 - 2017 (US$)
  • Figure 6-108: Allograft Craniomaxillofacial Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-109: Total Synthetic Market, Australia, 2007 - 2017 (US$)
  • Figure 6-110: Total Synthetic Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-111: Synthetic Total Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-112: Synthetic Total Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-113: Synthetic Cervical Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-114: Synthetic Cervical Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-115: Synthetic Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$)
  • Figure 6-116: Synthetic Thoracolumbar Spine Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-117: Synthetic Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$)
  • Figure 6-118: Synthetic Trauma & Reconstruction Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-119: Synthetic Craniomaxillofacial Market, Australia, 2007 - 2017 (US$)
  • Figure 6-120: Synthetic Craniomaxillofacial Market, Australia, 2007 - 2017 (AU$)
  • Figure 6-121: Drivers and Limiters, Bone Graft Substitute Market, Australia, 2010
  • Figure 6-122: Leading Competitors, Bone Graft Substitute Market, Australia, 2010
  • Figure 6-123: Leading Competitors, Bone Graft Substitute Market, Australia, 2010

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • Figure 7-1: Bone Morphogenetic Market, Australia, 2007 - 2017 (US$)
  • Figure 7-2: Bone Morphogenetic Market, Australia, 2007 - 2017 (AU$)
  • Figure 7-3: Drivers and Limiters, Bone Morphogenetic Protein Market, Australia, 2010
  • Figure 7-4: Leading Competitors, Bone Morphogenetic Protein Market, Australia, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 - 2017 (US$)
  • Figure 8-2: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 - 2017 (JP¥)
  • Figure 8-3: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
  • Figure 8-4: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
  • Figure 8-5: Total Hyaluronic Acid Viscosupplementation Market,
  • Figure 8-6: Total Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (CNY M)
  • Figure 8-7: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$)
  • Figure 8-8: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (CNY)
  • Figure 8-9: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$)
  • Figure 8-10: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (CNY)
  • Figure 8-11: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Figure 8-12: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Figure 8-13: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Figure 8-14: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (KR₩ M)
  • Figure 8-15: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$)
  • Figure 8-16: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 8-17: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$)
  • Figure 8-18: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (KR₩)
  • Figure 8-19: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Figure 8-20: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Figure 8-21: Hyaluronic Acid Viscosupplementation Market, Australia, 2007 - 2017 (US$)
  • Figure 8-22: Hyaluronic Acid Viscosupplementation Market, Australia, 2007 - 2017 (AU$)
  • Figure 8-23: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Australia, 2010
  • Figure 8-24: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2010

ABBREVIATIONS

APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT

  • Figure 10-1: Total Synthetic Market, Japan, 2007 - 2017 (US$)
  • Figure 10-2: Total Synthetic Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-3: Synthetic Total Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 10-4: Synthetic Total Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-5: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 10-6: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-7: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (US$)
  • Figure 10-8: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-9: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (US$)
  • Figure 10-10: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (JP¥)
  • Figure 10-11: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (US$)
  • Figure 10-12: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (JP¥)

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 11-1: Exchange Rate for Currencies, 2010
  • Figure 11-2: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 - 2017 (US$)
  • Figure 11-3: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 - 2017 (TW$)

APPENDIX 3: EMERGING MARKETS

LIST OF CHARTS

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

ASIA-PACIFIC ORTHOPEDIC BIOMATERIALS MARKET

  • Chart 3-1: Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017 (US$M)
  • Chart 3-2: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2007 - 2017 (US$M)
  • Chart 3-3: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2010
  • Chart 3-4: Orthopedic Biomaterials Market by Segment, Asia-Pacific, 2017
  • Chart 3-5: Growth Rates by Segment, Orthopedic Biomaterials Market, Asia-Pacific, 2007 - 2017
  • Chart 3-6: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2007 - 2017 (US$M)
  • Chart 3-7: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2010
  • Chart 3-8: Orthopedic Biomaterials Market by Country, Asia-Pacific, 2017
  • Chart 3-9: Orthopedic Biomaterials Market by Segment, Japan, 2007 - 2017 (US$M)
  • Chart 3-10: Orthopedic Biomaterials Market by Segment, Japan, 2010
  • Chart 3-11: Orthopedic Biomaterials Market by Segment, Japan, 2017
  • Chart 3-12: Orthopedic Biomaterials Market by Segment, China, 2007 - 2017 (US$M)
  • Chart 3-13: Orthopedic Biomaterials Market by Segment, China, 2010
  • Chart 3-14: Orthopedic Biomaterials Market by Segment, China, 2017
  • Chart 3-15: Orthopedic Biomaterials Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Chart 3-16: Orthopedic Biomaterials Market by Segment, South Korea, 2010
  • Chart 3-17: Orthopedic Biomaterials Market by Segment, South Korea, 2017
  • Chart 3-18: Orthopedic Biomaterials Market by Segment, Australia, 2007 - 2017 (US$M)
  • Chart 3-19: Orthopedic Biomaterials Market by Segment, Australia, 2010
  • Chart 3-20: Orthopedic Biomaterials Market by Segment, Australia, 2017
  • Chart 3-21: Leading Competitors, Orthopedic Biomaterials Market, Asia-Pacific, 2010
  • Chart 3-22: H-Index, Orthopedic Biomaterials Market, Asia-Pacific, 2010

COUNTRY PROFILES

  • Chart 4-1: Country Profile, Japan, 2010
  • Chart 4-2: Country Profile, China, 2010
  • Chart 4-3: Country Profile, South Korea, 2010
  • Chart 4-4: Country Profile, Australia, 2010

PROCEDURE NUMBERS

  • Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2010
  • Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication, Asia-Pacific, 2017
  • Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2010
  • Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment, Asia-Pacific, 2017
  • Chart 5-5: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2010
  • Chart 5-6: Total Orthopedic Bone Graft Substitute Procedures by Country, Asia-Pacific, 2017

BONE GRAFT SUBSTITUTE MARKET

  • Chart 6-1: Total Synthetic Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-2: Synthetic Total Spine Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-3: Synthetic Cervical Spine Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-4: Synthetic Thoracolumbar Spine Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-5: Synthetic Trauma & Reconstruction Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-6: Synthetic Craniomaxillofacial Market, Japan, 2007 - 2017 (US$M)
  • Chart 6-7: Leading Competitors, Bone Graft Substitute Market, Japan, 2010
  • Chart 6-8: Bone Graft Substitute Market by Segment, China, 2007 - 2017 (US$M)
  • Chart 6-9: Bone Graft Substitute Market by Segment, China, 2010
  • Chart 6-10: Bone Graft Substitute Market by Segment, China, 2017
  • Chart 6-11: Total Allograft Market, China, 2007 - 2017 (US$M)
  • Chart 6-12: Allograft Total Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-13: Allograft Cervical Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-14: Allograft Thoracolumbar Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-15: Allograft Trauma & Reconstruction Market, China, 2007 - 2017 (US$M)
  • Chart 6-16: Allograft Craniomaxillofacial Market, China, 2007 - 2017 (US$M)
  • Chart 6-17: Total Synthetic Market, China, 2007 - 2017 (US$M)
  • Chart 6-18: Synthetic Total Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-19: Synthetic Cervical Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-20: Synthetic Thoracolumbar Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-21: Synthetic Trauma & Reconstruction Market, China, 2007 - 2017 (US$M)
  • Chart 6-22: Synthetic Craniomaxillofacial Market, China, 2007 - 2017 (US$M)
  • Chart 6-23: Total DBM Market, China, 2007 - 2017 (US$M)
  • Chart 6-24: DBM Total Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-25: DBM Cervical Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-26: DBM Thoracolumbar Spine Market, China, 2007 - 2017 (US$M)
  • Chart 6-27: DBM Trauma & Reconstruction Market, China, 2007 - 2017 (US$M)
  • Chart 6-28: DBM Craniomaxillofacial Market, China, 2007 - 2017 (US$M)
  • Chart 6-29: Leading Competitors, Bone Graft Substitute Market, China, 2010
  • Chart 6-30: Bone Graft Substitute Market by Segment, South Korea, 2007 - 2017 (US$M)
  • Chart 6-31: Bone Graft Substitute Market by Segment, South Korea, 2010
  • Chart 6-32: Bone Graft Substitute Market by Segment, South Korea, 2017
  • Chart 6-33: Total Allograft Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-34: Allograft Total Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-35: Allograft Cervical Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-36: Allograft Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-37: Allograft Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-38: Allograft Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-39: Total Synthetic Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-40: Synthetic Total Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-41: Synthetic Cervical Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-42: Synthetic Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-43: Synthetic Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-44: Synthetic Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-45: Total DBM Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-46: DBM Total Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-47: DBM Cervical Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-48: DBM Thoracolumbar Spine Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-49: DBM Trauma & Reconstruction Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-50: DBM Craniomaxillofacial Market, South Korea, 2007 - 2017 (US$M)
  • Chart 6-51: Leading Competitors, Bone Graft Substitute Market, South Korea, 2010
  • Chart 6-52: Bone Graft Substitute Market by Segment, Australia, 2007 - 2017 (US$M)
  • Chart 6-53:Bone Graft Substitute Market by Segment, Australia, 2010
  • Chart 6-54: Bone Graft Substitute Market by Segment, Australia, 2017
  • Chart 6-55: Total Allograft Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-56: Allograft Total Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-57: Allograft Cervical Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-58: Allograft Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-59: Allograft Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-60: Allograft Craniomaxillofacial Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-61: Total Synthetic Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-62: Synthetic Total Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-63: Synthetic Cervical Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-64: Synthetic Thoracolumbar Spine Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-65: Synthetic Trauma & Reconstruction Market, Australia, 2007 - 2017 (US$M)
  • Chart 6-66: Synthetic Craniomaxillofacial Market, Australia, 2007 - 2017 (US$M)

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • Chart 7-1: Bone Morphogenetic Market, Australia, 2007 - 2017 (US$M)
  • Chart 7-2: Leading Competitors, Bone Morphogenetic Protein Market, Australia, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Chart 8-1: Hyaluronic Acid Viscosupplementation Market, Japan, 2007 - 2017 (US$M)
  • Chart 8-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2010
  • Chart 8-3: Total Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$M)
  • Chart 8-4: Total Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Chart 8-5: Total Hyaluronic Acid Viscosupplementation Market, China, 2017
  • Chart 8-6: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$M)
  • Chart 8-7: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, China, 2007 - 2017 (US$M)
  • Chart 8-8: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2010
  • Chart 8-9: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Chart 8-10: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Chart 8-11: Total Hyaluronic Acid Viscosupplementation Market, South Korea, 2017
  • Chart 8-12: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Chart 8-13: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, South Korea, 2007 - 2017 (US$M)
  • Chart 8-14: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, South Korea, 2010
  • Chart 8-15: Hyaluronic Acid Viscosupplementation Market, Australia, 2010 - 2017 (US$M)
  • Chart 8-16: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Australia, 2010

ABBREVIATIONS

APPENDIX 1: JAPANESE BONE GRAFT SUBSTITUTE MARKET BY WEIGHT

APPENDIX 2: TAIWANESE HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Chart 11-1: Hyaluronic Acid Viscosupplementation Market, Taiwan, 2007 - 2017 (US$M)

APPENDIX 3: EMERGING MARKETS

Back to Top